{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T09:46:52Z","timestamp":1782467212521,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25K02505"],"award-info":[{"award-number":["JP25K02505"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25K21766"],"award-info":[{"award-number":["JP25K21766"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP223fa627001"],"award-info":[{"award-number":["JP223fa627001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP253fa727002"],"award-info":[{"award-number":["JP253fa727002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007263","name":"Astellas Foundation for Research on Metabolic Disorders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007428","name":"Naito Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-74717-2","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T09:03:28Z","timestamp":1782464608000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Affinity- and epitope-dependent pathogenicity of GM-CSF autoantibodies in patients with autoimmune pulmonary alveolar proteinosis"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9990-0778","authenticated-orcid":false,"given":"Shinji","family":"Futami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3913-7330","authenticated-orcid":false,"given":"Jun-ichi","family":"Kishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9351-7855","authenticated-orcid":false,"given":"Hiroshi","family":"Kida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-hung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8717-1237","authenticated-orcid":false,"given":"Fumihiko","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8879-6685","authenticated-orcid":false,"given":"Takayuki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3994-874X","authenticated-orcid":false,"given":"Yoshikazu","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4749-7117","authenticated-orcid":false,"given":"Atsushi","family":"Kumanogoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6352-304X","authenticated-orcid":false,"given":"Tomohiro","family":"Kurosaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9972-6105","authenticated-orcid":false,"given":"Takeshi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"74717_CR1","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1056\/NEJM195806052582301","volume":"258","author":"SH Rosen","year":"1958","unstructured":"Rosen, S. H., Castleman, B. & Liebow, A. A. Pulmonary alveolar proteinosis. N. Engl. J. Med 258, 1123\u20131142 (1958).","journal-title":"N. Engl. J. Med"},{"key":"74717_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-019-0066-3","volume":"5","author":"BC Trapnell","year":"2019","unstructured":"Trapnell, B. C. et al. Pulmonary alveolar proteinosis. Nat. Rev. Dis. Prim. 5, 16 (2019).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"74717_CR3","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/S2213-2600(18)30043-2","volume":"6","author":"A Kumar","year":"2018","unstructured":"Kumar, A., Abdelmalak, B., Inoue, Y. & Culver, D. A. Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach. Lancet Respir. Med 6, 554\u2013565 (2018).","journal-title":"Lancet Respir. Med"},{"key":"74717_CR4","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1126\/science.8171324","volume":"264","author":"G Dranoff","year":"1994","unstructured":"Dranoff, G. et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264, 713\u2013716 (1994).","journal-title":"Science"},{"key":"74717_CR5","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1073\/pnas.91.12.5592","volume":"91","author":"E Stanley","year":"1994","unstructured":"Stanley, E. et al. Granulocyte\/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. USA 91, 5592\u20135596 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74717_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/1074-7613(95)90046-2","volume":"2","author":"R Nishinakamura","year":"1995","unstructured":"Nishinakamura, R. et al. Mice deficient for the IL-3\/GM-CSF\/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal. Immunity 2, 211\u2013222 (1995).","journal-title":"Immunity"},{"key":"74717_CR7","doi-asserted-by":"publisher","first-page":"9565","DOI":"10.1073\/pnas.92.21.9565","volume":"92","author":"L Robb","year":"1995","unstructured":"Robb, L. et al. Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc. Natl. Acad. Sci. USA 92, 9565\u20139569 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74717_CR8","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1084\/jem.190.6.875","volume":"190","author":"Kitamura","year":"1999","unstructured":"Kitamura et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte\/macrophage colony-stimulating factor. J. Exp. Med 190, 875\u2013880 (1999).","journal-title":"J. Exp. Med"},{"key":"74717_CR9","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1164\/rccm.202112-2742SO","volume":"205","author":"C McCarthy","year":"2022","unstructured":"McCarthy, C., Carey, B. C. & Trapnell, B. C. Autoimmune pulmonary alveolar proteinosis. Am. J. Respir. Crit. Care Med 205, 1016\u20131035 (2022).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"74717_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1164\/rccm.201001-0008OC","volume":"182","author":"T Sakagami","year":"2010","unstructured":"Sakagami, T. et al. Patient-derived granulocyte\/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates. Am. J. Respir. Crit. Care Med 182, 49\u201361 (2010).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"74717_CR11","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/thorax.58.3.252","volume":"58","author":"JF Seymour","year":"2003","unstructured":"Seymour, J. F. et al. Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis. Thorax 58, 252\u2013257 (2003).","journal-title":"Thorax"},{"key":"74717_CR12","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1164\/rccm.200708-1271OC","volume":"177","author":"Y Inoue","year":"2008","unstructured":"Inoue, Y. et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am. J. Respir. Crit. Care Med 177, 752\u2013762 (2008).","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"74717_CR13","doi-asserted-by":"publisher","first-page":"7832","DOI":"10.1073\/pnas.1216011110","volume":"110","author":"Y Wang","year":"2013","unstructured":"Wang, Y. et al. Characterization of pathogenic human monoclonal autoantibodies against GM-CSF. Proc. Natl. Acad. Sci. USA 110, 7832\u20137837 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74717_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8375","volume":"6","author":"L Piccoli","year":"2015","unstructured":"Piccoli, L. et al. Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis. Nat. Commun. 6, 7375 (2015).","journal-title":"Nat. Commun."},{"key":"74717_CR15","doi-asserted-by":"crossref","unstructured":"Kitamura, N. et al. Incidence of autoimmune pulmonary alveolar proteinosis estimated using Poisson distribution. ERJ Open Res. 5, 10.1183\/23120541.00190-2018 (2019).","DOI":"10.1183\/23120541.00190-2018"},{"key":"74717_CR16","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1111\/j.1440-1843.2006.00810.x","volume":"11","author":"Y Inoue","year":"2006","unstructured":"Inoue, Y. et al. Epidemiological and clinical features of idiopathic pulmonary alveolar proteinosis in Japan. Respirology 11, S55\u2013S60 (2006).","journal-title":"Respirology"},{"key":"74717_CR17","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20221786","volume":"220","author":"T Inoue","year":"2023","unstructured":"Inoue, T. et al. Antibody feedback contributes to facilitating the development of Omicron-reactive memory B cells in SARS-CoV-2 mRNA vaccinees. J. Exp. Med 220, e20221786 (2023).","journal-title":"J. Exp. Med"},{"key":"74717_CR18","doi-asserted-by":"crossref","unstructured":"Shinnakasu, R. et al. Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses. J. Exp. Med. 218, 10.1084\/jem.20211003 (2021).","DOI":"10.1084\/jem.20211003"},{"key":"74717_CR19","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.rmed.2004.08.011","volume":"98","author":"T Arai","year":"2004","unstructured":"Arai, T. et al. Serum neutralizing capacity of GM-CSF reflects disease severity in a patient with pulmonary alveolar proteinosis successfully treated with inhaled GM-CSF. Respir. Med 98, 1227\u20131230 (2004).","journal-title":"Respir. Med"},{"key":"74717_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/jcp.1041400219","volume":"140","author":"T Kitamura","year":"1989","unstructured":"Kitamura, T. et al. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J. Cell Physiol. 140, 323\u2013334 (1989).","journal-title":"J. Cell Physiol."},{"key":"74717_CR21","first-page":"1018","volume":"10","author":"U Dhagat","year":"2018","unstructured":"Dhagat, U. et al. The mechanism of GM-CSF inhibition by human GM-CSF auto-antibodies suggests novel therapeutic opportunities. MAbs 10, 1018\u20131029 (2018).","journal-title":"MAbs"},{"key":"74717_CR22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/sj.cr.7310017","volume":"16","author":"Y Shi","year":"2006","unstructured":"Shi, Y. et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don\u2019t know. Cell Res 16, 126\u2013133 (2006).","journal-title":"Cell Res"},{"key":"74717_CR23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.immuni.2007.05.001","volume":"26","author":"MG Manz","year":"2007","unstructured":"Manz, M. G. Human-hemato-lymphoid-system mice: opportunities and challenges. Immunity 26, 537\u2013541 (2007).","journal-title":"Immunity"},{"key":"74717_CR24","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1073\/pnas.1019682108","volume":"108","author":"T Willinger","year":"2011","unstructured":"Willinger, T. et al. Human IL-3\/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung. Proc. Natl. Acad. Sci. USA 108, 2390\u20132395 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74717_CR25","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1146\/annurev.physiol.64.090601.113847","volume":"64","author":"BC Trapnell","year":"2002","unstructured":"Trapnell, B. C. & Whitsett, J. A. Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu Rev. Physiol. 64, 775\u2013802 (2002).","journal-title":"Annu Rev. Physiol."},{"key":"74717_CR26","doi-asserted-by":"publisher","first-page":"13022","DOI":"10.1073\/pnas.1000475107","volume":"107","author":"LD Shultz","year":"2010","unstructured":"Shultz, L. D. et al. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD\/SCID\/IL2r gamma(null) humanized mice. Proc. Natl. Acad. Sci. USA 107, 13022\u201313027 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74717_CR27","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1182\/blood.V95.11.3357","volume":"95","author":"L Niu","year":"2000","unstructured":"Niu, L., Heaney, M. L., Vera, J. C. & Golde, D. W. High-affinity binding to the GM-CSF receptor requires intact N-glycosylation sites in the extracellular domain of the beta subunit. Blood 95, 3357\u20133362 (2000).","journal-title":"Blood"},{"key":"74717_CR28","doi-asserted-by":"publisher","first-page":"11346","DOI":"10.1073\/pnas.172229899","volume":"99","author":"A Nowakowski","year":"2002","unstructured":"Nowakowski, A. et al. Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody. Proc. Natl. Acad. Sci. USA 99, 11346\u201311350 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74717_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri.2017.106","volume":"18","author":"LL Lu","year":"2018","unstructured":"Lu, L. L., Suscovich, T. J., Fortune, S. M. & Alter, G. Beyond binding: antibody effector functions in infectious diseases. Nat. Rev. Immunol. 18, 46\u201361 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"74717_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.imlet.2014.11.001","volume":"163","author":"C Cornaby","year":"2015","unstructured":"Cornaby, C. et al. B cell epitope spreading: mechanisms and contribution to autoimmune diseases. Immunol. Lett. 163, 56\u201368 (2015).","journal-title":"Immunol. Lett."},{"key":"74717_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21011-y","volume":"12","author":"S Sakaue","year":"2021","unstructured":"Sakaue, S. et al. Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis. Nat. Commun. 12, 1032 (2021).","journal-title":"Nat. Commun."},{"key":"74717_CR32","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1111\/j.1440-1843.2006.00811.x","volume":"11","author":"R Tazawa","year":"2006","unstructured":"Tazawa, R., Nakata, K., Inoue, Y. & Nukiwa, T. Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report. Respirology 11, S61\u201364 (2006).","journal-title":"Respirology"},{"key":"74717_CR33","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200866","volume":"218","author":"T Inoue","year":"2021","unstructured":"Inoue, T. et al. Exit from germinal center to become quiescent memory B cells depends on metabolic reprograming and provision of a survival signal. J. Exp. Med 218, e20200866 (2021).","journal-title":"J. Exp. Med"},{"key":"74717_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/srep05885","volume":"4","author":"TS Dodev","year":"2014","unstructured":"Dodev, T. S. et al. A tool kit for rapid cloning and expression of recombinant antibodies. Sci. Rep. 4, 5885 (2014).","journal-title":"Sci. Rep."},{"key":"74717_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12896-015-0162-8","volume":"15","author":"K Motohashi","year":"2015","unstructured":"Motohashi, K. A simple and efficient seamless DNA cloning method using SLiCE from Escherichia coli laboratory strains and its application to SLiP site-directed mutagenesis. BMC Biotechnol. 15, 47 (2015).","journal-title":"BMC Biotechnol."},{"key":"74717_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","volume":"152","author":"DN Mastronarde","year":"2005","unstructured":"Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36\u201351 (2005).","journal-title":"J. Struct. Biol."},{"key":"74717_CR37","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"74717_CR38","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/s41592-019-0575-8","volume":"16","author":"T Bepler","year":"2019","unstructured":"Bepler, T. et al. Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs. Nat. Methods 16, 1153\u20131160 (2019).","journal-title":"Nat. Methods"},{"key":"74717_CR39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."},{"key":"74717_CR40","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr D. Biol. Crystallogr 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"74717_CR41","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1107\/S2059798318002425","volume":"74","author":"TI Croll","year":"2018","unstructured":"Croll, T. I. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr D. Struct. Biol. 74, 519\u2013530 (2018).","journal-title":"Acta Crystallogr D. Struct. Biol."},{"key":"74717_CR42","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1107\/S2059798321009475","volume":"77","author":"K Yamashita","year":"2021","unstructured":"Yamashita, K., Palmer, C. M., Burnley, T. & Murshudov, G. N. Cryo-EM single-particle structure refinement and map calculation using Servalcat. Acta Crystallogr D. Struct. Biol. 77, 1282\u20131291 (2021).","journal-title":"Acta Crystallogr D. Struct. Biol."},{"key":"74717_CR43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D. Biol. Crystallogr 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74717-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74717-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74717-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T09:03:37Z","timestamp":1782464617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74717-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74717"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74717-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.W. is an employee of KOTAI Biotechnologies, Inc. K.Y. is a founder and board member of KOTAI Biotechnologies, Inc. Other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5556"}}